Related Experiment Video
Updated: May 15, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm
T Michael O'Shea1, Bhavesh Shah2, Elizabeth N Allred3
1Division of Neonatology, Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Insights
Elevated inflammation markers in preterm infants
Area of Science:
- Neonatal research
- Biomarker discovery
- Developmental neuroscience
Background:
- Neonatal inflammation is a known risk factor for perinatal brain damage.
- Early identification of cognitive impairment risk is crucial for preterm infants.
Purpose of the Study:
- To determine if inflammation-related proteins in blood enhance risk prediction for impaired cognitive function.
- To assess the combined predictive value of clinical inflammatory illnesses and protein biomarkers.
Main Methods:
- Blood samples from 800 preterm infants (born <28 weeks gestation) analyzed for 25 inflammation proteins on days 1, 7, and 14.
- Clinical data on bacteremia, necrotizing enterocolitis (NEC), and ventilation collected.
- Cognitive function assessed at 2 years using the Bayley Mental Development Index (MDI).
Main Results:
- Clinical factors like NEC and bacteremia combined with ventilation predicted elevated risk for MDI <55.
- Persistently or recurrently elevated levels of CRP, SAA, IL-6, TNF-alpha, IL-8, MIP-1beta, ICAM-1, E-SEL, and IGFBP-1 provided additional risk information.
- Biomarker data supplemented clinical data in predicting cognitive outcomes.
Conclusions:
- Elevated blood inflammation protein concentrations offer valuable information for predicting impaired cognitive function.
- Biomarkers augment clinical data, improving risk assessment for cognitive deficits in preterm infants.
- This finding supports the use of inflammation markers for early intervention strategies.
Abstract:
Neonatal inflammation is associated with perinatal brain damage. We evaluated to what extent elevated blood levels of inflammation-related proteins supplement information about the risk of impaired early cognitive function provided by inflammation-related illnesses. From 800 infants born before the 28th week of gestation, we collected blood spots on days 1, 7 and 14, for analysis of 25 inflammation-related proteins, and data about culture-positive bacteremia, necrotizing enterocolitis (Bell stage IIIb), and isolated perforation of the intestine, during the first two weeks, and whether they were ventilated on postnatal day 14. We considered a protein to be persistently or recurrently elevated if its concentration was in the top quartile (for gestational age and day blood was collected) on two separate days one week apart. We assessed the children at 2 years of age with the Bayley Mental Development Index (MDI). The combinations of NEC and ventilation on day 14, and of bacteremia and ventilation on day 14 consistently provided information about elevated risk of MDI <55, regardless of whether or not a variable for an elevated protein concentration was included in the model. A variable for a persistently or recurrently elevated concentration of each of the following proteins provided additional information about an increased risk of MDI <55: CRP, SAA, IL-6, TNF-alpha, IL-8, MIP-1beta, ICAM-1, E-SEL, and IGFBP-1. We conclude that elevated blood concentrations of inflammation-related proteins provide information about the risk of impaired cognitive function at age 2 years that supplements information provided by inflammation-associated illnesses.
More Related Videos
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Acute Inflammation III: Local and Systemic Effects
Bacterial Meningitis I: Introduction

